Brain Abscess Due to Listeria Monocytogenes, Five Cases and a Review of the Literature
Medicine 80:223-235, Eckburg,P.B.,et al, 2001
An ALS-Like Syndrome with New HIV Infection and Complete Response to Antiretroviral Therapy
Neurol 57:1094-1097,945, MacGowan,D.J.L.,et al, 2001
Reversible ALS-Like Disorder in HIV Infection
Neurol 57:995-1001,945, Moulignier,A.,et al, 2001
Acute Disseminated Encephalomyelitis as Manifestation of Primary HIV Infection
Neurol 57:1493-1496, Narciso,P.,et al, 2001
The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001
Primary Lymphoma of the Pituitary: An Emerging Clinical Entity
J Clin Endocrinol Metab 86:4567-4575, Giustina,A.,et al, 2001
Glioblastoma Multiforme in a Case of Acquired Immunodeficiency Syndrome: Investigation a Possible Oncogenic Influence of Human Immunodeficiency Virus on Glial Cells. Case Report and Review of the Lite
J Neurosurg 92:161-164, Vannemreddy,P.S.,eet al, 2000
Cytomegalovirus Ventriculoencephalitis Presenting as a Wernicke's Encephalopathy-like Sydrome
Neurol 55:1910-1913, Torgovnick,J.,et al, 2000
Adverse Effects of Antiretroviral Therapy
Lancet 356:1423-1430, Carr,A. &Cooper, D.A., 2000
West Nile Viral Encephalitis in an HIV-Positive Woman in New York
NEJM 342:59-60, Szilak,I.&Minamoto,G.Y., 2000
Toxoplasmosis Manifesting as Hydroephalus on Computed Tomography
Infect Dis Clin Practice 9:390-392, Finelli,P.F. &Uphoff,D.F., 2000
Remedies for HIV-associated Peripheral Neuropathy
Neurol 54:2037-2038, Berger,J.R. &Nath,A., 2000
Effect of Interferon B-1b in MS, Assessment of Annual Accumulation of PD/T2 Activity on MRI
Neurol 54:200-206, Zhao,G.J.,et al, 2000
Remission of HIV Myelopathy After Highly Active Antiretroviral Therapy
Neurol 54:267-268, Staudinger,R.&Henry,K., 2000
St Louis Encephalitis,A Review of 11 Cases in a 1995 Dallas, Tex, Epidemic
Arch Neurol 57:114-118, Wasay,M.,et al, 2000
Congenital Muscular Dystrophy with Rigid Spine Syndrome:A Clinical, Pathological, Radiological, and Genetic Study
Ann Neurol 47:152-161, 143, Flanigan,K.M.,et al, 2000
Role of Brain Biopsy in the Management of Focal Brain Lesions in HIV-Infected Patients
Neurol 54:993-997, Antinori,A.,et al, 2000
Glatiramer Acetate (Copaxone) Treatment in Relapsing-Remitting MS
Neurol 54:813-817, Ge,Y.,et al, 2000
Screening CT of the Brain Determined by CD4 Count in HIV-Positive Patients Presenting with Headache
AJNR 21:451-454,441, Graham III,C.B.,et al, 2000
Remedies for HIV-Associated Peripheral Neuropathy
Neurol 54:2037-2038, Berger,J.R.&Nath,A., 2000
Decreasing Incidence of CNS AIDS-Defining Events Associated with Antiretroviral Therapy
Neurol 54:1856-1859, d'Arminion Monforte,A.,et al, 2000
Highly Active Antiretroviral Therapy for Patients with AIDS Dementia Complex: Effect on MR Imaging Findings and Clinical Course
AJNR 21:670-678, Thurnher,M.M.,et al, 2000
Therapeutic Dilemma
Neurol 54:1404-1407, Romanelli,F.,et al, 2000
Human Immunodeficiency Virus-Associated Pure motor Lumbosacral Polyradiculopathy
Arch Neurol 57:1034-1039, Benatar,M.G. & Eastman,R.W., 2000
Epstein-Barr Virus Infection
NEJM 343:481-492, Cohen,J.I., 2000
Central Nervous System Aspergillosis in Patients with Human Immunodeficiency Virus Infection
Medicine 79:269-280, Mylonakis,E. et al, 2000
Evolution of Sporadic Olivopontocerebellar Atrophy Into Multiple System Atrophy
Neurol 55:527-532, Gilman,S. et al, 2000
Incidence and Prevalence of Neurological Disorders Associated with HIV Since the Introduction of Highly Active Antiretroviral Therapy (HAART)
JNNP 69:376-380, Maschke,M. et al, 2000
Cerebral Infarction in Adult AIDS Patients
Stroke 31:2117-2126, Connor,M.D. et al, 2000
Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000
Intramuscular Interferon Beta-1a Therapy Initiated During a First Demyelinating Event in Multiple Sclerosis
NEJM 343:898-904, Jacobs,L.D. et al, 2000
Progressive Multifocal Leucoencephalopathy: Progress in the AIDS Era
JNNP 69:569-571, Manji,H. & Miller,R.F., 2000
AIDS-Related Focal Brain Lesions in the Era of Highly Active Antiretroviral Therapy
Neurol 55:1194-1200, Ammassari,A.,et al, 2000
New-Onset Seizures Associated with HIV Infection
Neurol 55:1558-1560, Modi,G.,et al, 2000
SPECT Thallium-201 Combined with Toxoplasma Serology for the Presumptive Diagnosis of Focal Central Nervous System Mass Lesions in Patients with AIDS
J Inf 40:274-281, Skiest, D.J.,et al, 2000
The Central Nervous system and Infection by Candida Species
Diagn Microbial Infect Dis 37:169-179, Sanchez-Portocarrero, J.,et al, 2000
What Level of Care for the Neurofibromatoses?
Lancet 353:1114-1116, Huson,S.M., 1999
Neurologic Manifestations of AIDS in Older Adults
Infect Dis Clin Practice 8:179-185, Finelli,P.F.,et al, 1999
Neurology and the Skin
JNNP 66:417-430, Hurko,O.&Provost,T.T., 1999
Proton Magnetic Resonance Spectroscopy Pattern of Progressive Multifocal Leukoencephalopathy in AIDS
JNNP 66:520-523, Iranzo,A.,et al, 1999
Prospective Study of New-Onset Seizures in Patients with Human Immunodeficiency Virus Infection
Arch Neurol 56:609-612, Pascual-Sedano,B.,et al, 1999
Primary Intracranial Neoplasms in Patients with HIV
Neurol 52:1648-1651, Blumenthal,D.T.,et al, 1999
Hyperintense Basal Ganglia on T1-Weighted MR Imaging
AJR 172:1109-1115, Lai,P.H.,et al, 1999
Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999
Neurological Complications of Neurofibromatosis Type 1 in Adulthood
Brain 122:473-481, Creange,A.,et al, 1999
Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999
Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999
Highly Active Antiretroviral Therapy Reverses Brain Metabolite Abnormalities in Mild HIV Dementia
Neurol 53:782-789, Chang,L.,et al, 1999
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999
Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999